Purchases and Sales Made in Q3 2024 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q3 2024. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-286K- 89.2% |
$5.41M - $7.35M
|
34.6K
$418K
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-308K- 31.35% |
$5.82M - $7.9M
|
674K
$8.14M
|
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-337K- 12.45% |
$6.38M - $8.66M
|
2.37M
$28.7M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-378K- 63.02% |
$7.15M - $9.71M
|
222K
$2.68M
|
|
|
Nov 14, 2024
Q3 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-990K- 48.16% |
$18.7M - $25.4M
|
1.07M
$12.9M
|